CN105601504B - A kind of preparation method of 2 (xenyl of 2 fluorine 4) propionic acid - Google Patents
A kind of preparation method of 2 (xenyl of 2 fluorine 4) propionic acid Download PDFInfo
- Publication number
- CN105601504B CN105601504B CN201610192096.5A CN201610192096A CN105601504B CN 105601504 B CN105601504 B CN 105601504B CN 201610192096 A CN201610192096 A CN 201610192096A CN 105601504 B CN105601504 B CN 105601504B
- Authority
- CN
- China
- Prior art keywords
- preparation
- fluoro
- xenyls
- zincon
- propionic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 title claims abstract description 68
- 235000019260 propionic acid Nutrition 0.000 title claims abstract description 34
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 229910052731 fluorine Inorganic materials 0.000 title abstract description 6
- 239000011737 fluorine Substances 0.000 title abstract description 5
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 title abstract 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 51
- OWQUYBAASOSGNO-CDNKMLFNSA-N 2-[[(Z)-N-(2-hydroxy-5-sulfoanilino)-C-phenylcarbonimidoyl]diazenyl]benzoic acid Chemical compound C1=CC=C(C=C1)/C(=N/NC2=C(C=CC(=C2)S(=O)(=O)O)O)/N=NC3=CC=CC=C3C(=O)O OWQUYBAASOSGNO-CDNKMLFNSA-N 0.000 claims abstract description 27
- 229940043798 zincon Drugs 0.000 claims abstract description 27
- 230000007062 hydrolysis Effects 0.000 claims abstract description 16
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 16
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 13
- BGJKXDPDBUTQTP-UHFFFAOYSA-N CN(C)C.[SiH4].Cl Chemical compound CN(C)C.[SiH4].Cl BGJKXDPDBUTQTP-UHFFFAOYSA-N 0.000 claims abstract description 11
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 11
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 11
- 239000003054 catalyst Substances 0.000 claims abstract description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 62
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 31
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 16
- ARFLASKVLJTEJD-UHFFFAOYSA-N ethyl 2-bromopropanoate Chemical compound CCOC(=O)C(C)Br ARFLASKVLJTEJD-UHFFFAOYSA-N 0.000 claims description 15
- 239000012074 organic phase Substances 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 8
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical group C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 8
- 239000012298 atmosphere Substances 0.000 claims description 5
- 238000005660 chlorination reaction Methods 0.000 claims description 5
- 229910052759 nickel Inorganic materials 0.000 claims description 5
- AIVAIUMRPBQMLT-UHFFFAOYSA-N 3-acetylpentane-2,4-dione;nickel Chemical compound [Ni].CC(=O)C(C(C)=O)C(C)=O AIVAIUMRPBQMLT-UHFFFAOYSA-N 0.000 claims description 3
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical class Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- FSRXIRGQJIHEFB-UHFFFAOYSA-N diphenylphosphane;ethane Chemical compound CC.C=1C=CC=CC=1PC1=CC=CC=C1 FSRXIRGQJIHEFB-UHFFFAOYSA-N 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 150000002240 furans Chemical class 0.000 claims 1
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical class CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 abstract description 48
- 238000000034 method Methods 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 230000035484 reaction time Effects 0.000 abstract description 5
- 239000003446 ligand Substances 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 3
- 239000012190 activator Substances 0.000 abstract description 2
- 238000006555 catalytic reaction Methods 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 239000012535 impurity Substances 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract description 2
- 238000009434 installation Methods 0.000 abstract description 2
- 238000012805 post-processing Methods 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 4
- 235000010290 biphenyl Nutrition 0.000 abstract 2
- 239000004305 biphenyl Substances 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- UMIVDQOVSJFWOH-UHFFFAOYSA-N C1(=CC=CC=C1)C1=CC=CC=C1.[F] Chemical group C1(=CC=CC=C1)C1=CC=CC=C1.[F] UMIVDQOVSJFWOH-UHFFFAOYSA-N 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 63
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- 239000000243 solution Substances 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000000047 product Substances 0.000 description 16
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 12
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- 239000012043 crude product Substances 0.000 description 10
- 229960002390 flurbiprofen Drugs 0.000 description 10
- 239000003208 petroleum Substances 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- MONMFXREYOKQTI-UHFFFAOYSA-N 2-bromopropanoic acid Chemical compound CC(Br)C(O)=O MONMFXREYOKQTI-UHFFFAOYSA-N 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 125000004494 ethyl ester group Chemical group 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- 239000012046 mixed solvent Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000000967 suction filtration Methods 0.000 description 4
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- -1 corrosion inhibiter Substances 0.000 description 3
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 235000006506 Brasenia schreberi Nutrition 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 208000016247 Soft tissue disease Diseases 0.000 description 1
- 201000002661 Spondylitis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000013563 matrix tablet Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/04—Calcium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
Description
Claims (6)
- A kind of 1. preparation method of 2- (the fluoro- 4- xenyls of 2-) propionic acid, it is characterised in that:Comprise the following steps:1)The preparation of zinconIn inert atmosphere, zinc powder, trimethyl ammonia chloride silane and tetrahydrofuran are taken, is heated to flowing back after mixing, add 2 bromopropionic acid Ethyl ester, 1 ~ 4h of back flow reaction at 65 ~ 70 DEG C of temperature, obtains zincon;2)The synthesis of 2- (the fluoro- 4- xenyls of 2-) propionic acidIn inert atmosphere, zincon is added in the mixed liquor of the bromo- 2- fluorine biphenyl of 4-, catalyst, part and tetrahydrofuran, in temperature 3 ~ 8h of back flow reaction at 60 ~ 70 DEG C of degree, terminating reaction, solvent is removed after isolating organic phase, is hydrolyzed, is produced;Step 2)The bromo- 2- fluorine biphenyl of middle 4-, catalyst, part, the mass ratio of tetrahydrofuran are 1:0.01~0.03:0.02~ 0.06:3~6;Step 2)The addition of middle zincon is 3 ~ 5 times of the bromo- 2- fluorine biphenyl quality of 4-;Step 2)Middle catalyst is 1,2- double (diphenylphosphine) ethane chlorination nickel, diacetyl acetone nickel or nickel chlorides;Step 2)Middle part is triphenylphosphine or terpyridyl.
- 2. preparation method according to claim 1, it is characterised in that:Step 1)Middle zinc powder, trimethyl ammonia chloride silane, tetrahydrochysene The mass ratio of furans is 1:0.1~0.5:1~2.
- 3. preparation method according to claim 1 or 2, it is characterised in that:Step 1)Middle zinc powder and 2 bromopropionic acid ethyl ester Mass ratio is 1:2~3.
- 4. preparation method according to claim 1, it is characterised in that:Step 1)Before 2 bromopropionic acid ethyl ester is added, first make The mass ratio of the tetrahydrofuran solution of standby 2 bromopropionic acid ethyl ester, 2 bromopropionic acid ethyl ester and tetrahydrofuran is 1:1.5~3.
- 5. preparation method according to claim 1, it is characterised in that:Step 2)Middle back flow reaction terminates, and system is placed in Cool in ice bath, and add hydrochloric acid solution terminating reaction.
- 6. preparation method according to claim 1, it is characterised in that:Step 2)Middle hydrolysis is entered under acid or alkaline conditions OK, refined after hydrolysis, produce 2- (the fluoro- 4- xenyls of 2-) propionic acid sterling.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610192096.5A CN105601504B (en) | 2016-03-30 | 2016-03-30 | A kind of preparation method of 2 (xenyl of 2 fluorine 4) propionic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610192096.5A CN105601504B (en) | 2016-03-30 | 2016-03-30 | A kind of preparation method of 2 (xenyl of 2 fluorine 4) propionic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105601504A CN105601504A (en) | 2016-05-25 |
CN105601504B true CN105601504B (en) | 2018-01-09 |
Family
ID=55981933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610192096.5A Active CN105601504B (en) | 2016-03-30 | 2016-03-30 | A kind of preparation method of 2 (xenyl of 2 fluorine 4) propionic acid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105601504B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109956865B (en) * | 2017-12-22 | 2022-09-13 | 浙江瑞博制药有限公司 | Preparation method of sitagliptin intermediate |
CN108558651A (en) * | 2018-06-13 | 2018-09-21 | 上海峰林生物科技有限公司 | A kind of preparation method of Flurbiprofen and the preparation method of flurbiprofen axetil |
CN112778127A (en) * | 2020-06-25 | 2021-05-11 | 北京澳合药物研究院有限公司 | Preparation method of flurbiprofen |
CN112778115B (en) * | 2021-01-26 | 2022-08-09 | 山东师范大学 | Preparation method of flurbiprofen |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1027539C (en) * | 1990-12-22 | 1995-02-01 | 中国科学院上海有机化学研究所 | Trifluoride isopropenyl zinc reagent and its derivatives, preparation and application |
-
2016
- 2016-03-30 CN CN201610192096.5A patent/CN105601504B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN105601504A (en) | 2016-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105601504B (en) | A kind of preparation method of 2 (xenyl of 2 fluorine 4) propionic acid | |
CN105111205B (en) | A kind of preparation method of Pa Boxini | |
CN102875493B (en) | The method of epoxy aliphatic acid methyl ester is prepared in Continuous Flow micro passage reaction | |
CN109704405A (en) | A kind of preparation method of hollow flower ball-shaped vanadium disulfide | |
CN102304024B (en) | Method for synthesizing difluoroethanol | |
CN106083651A (en) | The new technique for synthesizing of salicylonitrile | |
CN107200683A (en) | A kind of preparation method for being used to treat type II diabetes Dapagliflozin intermediate | |
CN112125825A (en) | Preparation formula of 4' -bromomethyl-2-cyanobiphenyl | |
CN103936809A (en) | Improved preparation method of dexamethasone sodium phosphate intermediate | |
CN110423186A (en) | A method of producing phloroglucin | |
CN113666805B (en) | Method and system for continuously producing 4-chloro-3, 5-dimethylphenol | |
CN105175294B (en) | Method for synthesizing sulfanilamide by using chlorobenzene as raw material | |
CN109467515A (en) | The synthetic method of intermediate l-Alanine isopropyl ester hydrochloride | |
CN107382715A (en) | A kind of parachlorobenzoyl chloride preparation method | |
CN102211993A (en) | Industrial preparation method of (E)-trimethyl-2-hexenoic acid | |
CN106478431A (en) | A kind of method of synthesis of trans hexamethylene dimethylamine | |
CN105461521B (en) | The synthetic method of 2- chloroethyl propyl ethers | |
CN111100180A (en) | Synthesis method of stearyl glycyrrhetinate | |
CN113620825B (en) | Microchannel reactor and method for preparing ethyl dimethylaminoacetate by using microchannel reactor | |
CN109293578A (en) | A kind of preparation method of the chloro- 5- nitro-pyrimidine of 2,4- bis- | |
CN110229129A (en) | A kind of device and method thereof preparing 4- chloride anhydride | |
CN104945458A (en) | Progesterone synthesis method | |
CN106366034B (en) | A kind of preparation method of 3-Pyridineacetic Acid hydrochloride | |
CN113979965B (en) | Continuous production method of 4, 5-dichloro-2-octyl-4-isothiazolin-3-ketone | |
CN115536568B (en) | Method for continuously synthesizing chlorfenapyr |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Shu Qunwei Inventor after: Yang Yong Inventor after: Wang Jianli Inventor after: Zhao Pingping Inventor after: Hao Jiajin Inventor after: Hu Xiaolun Inventor after: Yang Guangyuan Inventor after: Wu Xiaojun Inventor before: Yang Yong Inventor before: Wang Jianli Inventor before: Zhao Pingping Inventor before: Hao Jiajin Inventor before: Hu Xiaolun Inventor before: Yang Guangyuan Inventor before: Wu Xiaojun |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 6, No. 4, No. 52, No. 4, Huang Yang Street, high tech Industrial Development Zone, Zhengzhou City, Henan Province, 41 Patentee after: Zhengzhou principle Biological Technology Co., Ltd. Address before: No. 41, No. 4, No. 4, phase 2, long Ding enterprise center of electronic and electrical appliances Industrial Park, Henan Province Patentee before: Zhengzhou Sigma Chemical Co., Ltd. |